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INTRODUCTION 
As a sequel to the discovery that l'nitochondria contain an independent 
system of protein synthesis (1-3), many efforts have been devoted toward 
identifying the products formed and understanding their role in the mor-
phogenesis of the organelle. Since mitochondria synthesize relatively few 
proteins, this work has progressed rapidly and there is presently a substan-
tial body of knowledge about the synthesis, genetic origin, and, in some 
instances, the functions of this interesting dass of proteins. This review 
summarizes some of the information that has emerged from studies of the 
past ten years and speculates on the future course of research in this area. 
MITOCHONDRIAL TRANSLATION PRODUCTS 
In Vivo Studies 
Some of the earliest evidence, particularly from work done with yeast, 
indicated that the proteins synthesized in mitochondria were likely to be 
components of the terminal respiratory pathway. For example, it was 
known that in yeast, chloramphenicol and other selective inhibitors of 
mitochondrial ribosomes, blocked the development of a functional cyto-
chrome system but had no pronounced effect on most of the other en-
zymatic machinery of the organelle (4, 5). A similar phenotype was found 
in cytoplasmic "petite" mutants of yeast (6) which are deficient in mito-
chondrial protein synthesis due to the loss of genetic information coding for 
mitochondrial ribosomal and transfer RNAs (7-9). 
Based on these observations, a number of laboratories began to systemat-
ically study the relationship of mitochondrial translation products to the 
enzymes that were known to catalyze electron transport (10). These in-
cluded the NADH- and succinate-coenzyme QHrreductase (10-12), coen-
zyme QHrcytochrome c reductase (13), and cytochrome oxidase (14). 
In addition to the four respiratory complexes, the oligomycin-sensitive 
ATPase which normally functions as an ATP synthetase (15, 16) was 
also suspected to contain mitochondrially derived. polypeptides since only 
one part of this important inner membrane complex was synthesized in 
petite mutants or in yeast grown in the presence of chloramphenicol (17, 
18). 
The biosynthesis of the respiratory and ATPase complexes was first 
examined in the yeast Saccharomyces cerevisiae and in Neurospora crassa, 
each organism offering distinct experimental advantages for such studies. 
Several circumstances facilitated the translational sites of the subunit poly-
peptides to be established by rather straightforward in vivo labeling experi-
ments. 
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1. Total cellular proteins could be labeled with high specific activity when 
cells were incubated in the presence of a radioactive precursor. 
2. Antibiotics were available which selectively inhibited either mitochon-
drial or cytoplasmic protein synthesis. 
3. The successful purification of the ATPase and some of the respiratory 
complexes of yeast and Neurospora made it possible to characterize their 
subunit compositions and at the same time provided the antibodies 
necessary for rapid isolation of the enzymes from small samples of cells. 
In most studies, the protocol used to identify the mitochondrially trans-
lated subunits consisted of labeling cells with a radioactive amino acid in 
the presence of either an inhibitor of mitochondrial or cytoplasmic protein 
synthesis. Subsequent purification of the enzymes and analysis of the distri-
bution of radioactivity in the various subunit polypeptides under each set 
of labeling conditions allowed their translation to be ascribed to either one 
of the two protein synthesizing systems. 
When S. cerevisiae, N. crassa, or mammalian cells are labeled in the 
presence of cycloheximide, 8-10 prominant radioactive protein bands are 
seen in polyacrylamide gels of mitochondria solubilized with sodium dode-
cyl sulfate (19, 20). Minor bands are also occasionally observed but they 
most likely arise from incomplete inhibition of cytoplasmic protein synthe-
sis. Similar results have been obtained in the absence of inhibitors by using 
a conditional mutant of yeast in which protein synthesis on cytoplasmic 
ribosomes is suppressed at the nonpermissive temperature (21) or by label-
. ing wild type cells with fMet. Mitochondrial products can be selectively 
labeled with fMet since it is used as the initiator and the formyl group is 
retained in the completed polypeptide chain due to the absence of a defor-
mylase (22). Most of the major mitochondrial translation products of yeast 
and Neurospora have been ascertained to be subunit polypeptides of the 
respiratory and ATPase complexes. The one exception is the protein desig-
nated as var 1. This mitochondrial product exhibits molecular weight vari-
ant forms (40,000-43,000 daltons) in different strains of yeast (23). The 
function of var 1 is still obscure but there are some indications that it might 
be a component of mitochondrial ribosomes (24). 
Identity of Mitochondrial Products 
The information currently available on the synthesis of the subunits of 
coenzyme QHrcytochrome c reductase, cytochrome oxidase, and ATPase 
is summarized below. Since both NADH- and succinate-coenzyme Q-
reductases are synthesized exclusively on cytoplasmic ribosomes (25-28), 
relatively few studies have been devoted to these complexes and they are 
not further considered here. 
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CYTOCHROME OXIDASE: Cytochrome oxidase is composed of seven 
nonidentical subunit polypeptides with molecular weights ranging from 
40,000-9,000 (29-32). The functional groups of the native enzyme are heme 
a (cytochromes a and a3) and copper. Following depolymerization of 
cytochrome oxidase with denaturing agents, heme a has been found to 
copurify with subunit 1 (40,000 daltons) (33) and subunit 7 (9,000 daltons) 
(34) which suggests that they are the hemoprotein components of the 
complex. In general, however, the precise relationship of the redox carriers 
to the enzyme subunits is still not agreed upon. 
The first demonstration that cytochrome oxidase is synthesized jointly on 
mitochondrial and cytoplasmic ribosomes came from studies on N. crassa 
(29). It was conclusively established from in vivo labeling experiments that 
the three largest polypeptides (subunits 1-3) of the enzyme are translated 
in mitochondria and that the low molecular weight polypeptides (subunits 
4--7) are made externally on cytoplasmic ribosomes (35, 36). This was later 
confirmed in S. cerevisiae (37, 38) and Xenopus laevis (39) and appears to 
be an invariant feature of the mechanism of biosynthesis of cytochrome 
oxidase. 
COENZYME QH2-CYTOCHROME REDUCTASE This intermediary res-
piratory complex was first purified and characterized from bovine heart 
mitochondria (13). Homogeneous preparations of coenzyme QHrcyto-
chrome c reductase have recently also been obtained from yeast (40) and 
N. crassa (41). It is composed of seven or eight different subunits not all 
of whose functions are known. The best understood components of the 
enzyme are cytochromes b, Cl' and a nonheme iron protein. Each has been 
shown to be an obligatory electron carrier in the catalysis of cytochrome 
c reduction (13, 42). Weiss (43, 44) found that in N. crassa, cytochrome 
b is synthesized in mitochondria. Although it was or:..ginally thought that 
there are two different cytochrome b apoproteins (45), more recent genetic 
and biochemical evidence suggests the presence of only one chemical species 
of this cytochrome (46, 47). Cytochrome b has also been shown to be 
synthesized by yeast mitochondria (48) and in fact appears to be the only 
subunit of coenzyme QHrcytochrome c reductase that has a mitochondrial 
origin-all the other subunits, including cytochrome Cl (49), are synthe-
sized in the cytoplasm. There are no reports at present that deal with the 
biosynthesis of this complex in higher animal and plant cells. 
OLIGOMYCIN-SENSITIVE ATPase This is probably the most intricate 
enzyme of the mitochondrial inner membrane. It is concerned not only with 
the coupling of the energy of oxidation to A TP synthesis but also with the 
utilization of the energy of hydrolysis of A TP for various energy-dependent 
functions such as ion transport, pyridine nucleotide transhydrogenation, 
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and reverse electron flow (15, 16, 50). This multiplicity of functions is 
reflected in the large number of polypeptides that have been attributed to 
the ATPase. The yeast complex consists of at least ten different protein 
subunits (51) none of whose functions can be clearly stated at present. 
The oligomycin-sensitive ATPase complexes of bovine heart and yeast 
mitochondria have been dissected into three fractions that can spontane-
ously reassociate to form the native enzyme (52, 53). The three reconstitu-
tively active fractions are Fl (54), OSCP (55), and a set of hydrophobic 
proteins referred to as the membrane factor (52). Fl is a water-soluble 
polymeric protein with a molecular weight of 340,000 (56). It is comprised 
of five distinct subunit polypeptides and catalyzes the hydrolysis of ATP-
this hydrolytic reaction, however, is not inhibited by oligomycin and other 
potent inhibitors of the native complex (16,54). In yeast (18), N. crassa (57, 
58), and X laevis (39), the five subunits of Flare synthesized in the cyto-
plasm. It is interesting that chloroplast F 1 which is structurally and func-
tionally related to the mitochondrial F h contains some subunits that are 
made on chloroplast ribosomes (59). 
OSCP is a water-soluble protein (17,000 daltons) that has been postulated 
to act as a link between Fl and the membrane factor (60, 61). This protein 
has been shown to be synthesized on cytoplasmic ribosomes in yeast (61). 
A cytoplasmic origin may also be assumed for the OSCP component of 
other mitochondrial A TPases, although this has not been experimentally 
verified. 
The membrane factor is composed of hydrophobic proteins that are 
highly insoluble in water. Unlike Fl and OSCP which are peripherally 
bound to the inner membrane, the polypeptides of the membrane factor are 
intrinsic proteins that are lodged in the lipid bilayer (62). The biosynthesis 
of the membrane factor has been studied in yeast, N. crassa, and X laevis 
and intriguing differences have been noted. The ATPase of S. cerevisiae 
contains four mitochondrially translated subunits which correspond to the 
membrane factor (63). In N. crassa, only two of the ATPase subunits have 
been found to originate in mitochondria (57, 58). The best evidence con-
cerns the DCCD-binding or proteolipid subunit of the membrane factor. 
This is a low molecular weight protein (7,800 daltons) that has been clearly 
demonstrated to be a mitochondrial product in yeast (64, 65) and a cyto-
plasmic product in N. crassa (66). The ATPase of X laevis has been 
reported to have three mitochondrially synthesized subunits (39). The rela-
tionship of the mitochondrial products of this enzyme to those of S. cerevi-
siae and N. crassa, however, has not been established (58). 
Regulation of Synthesis of Mitochondrial Products 
Normally mitochondrial and cytoplasmic products are continuously syn-
thesized and used for the assembly of the larger enzyme entities. In order 
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for this process to be efficient, the two sets of proteins must be produced 
in a stoichiometric fashion, which implies the existence of some sort of 
coordinate regulation of the two translational systems (for review see 20). 
In fact there is good evidence that the rate and extent of mitochondrial 
protein synthesis are influenced by cytoplasmic translation products. When 
yeast is inhibited with cycloheximide, mitochondrial protein synthesis pro-
ceeds at low rates and for only short duration (67). The rate of synthesis 
in the presence of cycloheximide is substantially increased if the cells are 
first incubated in chloramphenicol (67, 68). Presumably, the preincubation 
leads to an accumulation of cytoribosomal products which stimulate mito-
chondrial translation upon shifting to cycloheximide. 
Cytoplasmic factors have also been observed to affect mitochondrial 
protein synthesis in vitro. Poyton & Kavanagh (69) have reported that the 
synthesis of cytochrome oxidase subunits in isolated mitochondria is stimu-
lated by a crude postribosomal fraction of yeast and that the stimulation 
is proportional to the amount of supernatant added. More significantly, the 
effect was abolished when antibodies were used to adsorb cytochrome oxi-
dase specific proteins from the cytosolic fraction (69). These experiments 
suggest that the synthesis of mitochondrial subunits of cytochrome oxidase 
depends on the presence of their cytoplasmically made counterparts. It is 
not unreasonable that the synthesis of mitochondrial translation products 
is tightly coupled to their integration with cytoplasmic subunits and that 
interruption of the assembly sequence due to the absence of one or more 
proteins may suppress further synthesis on mitochondrial ribosomes. 
The trivial explanation, namely that unassembled mitochondrial subunits 
are more susceptible to degradative enzymes, cannot be excluded how-
ever. 
In addition to the biochemical evidence there are indications from genetic 
data of the involvement of cytoplasmic products in the regulation of mito-
chondrial protein synthesis. Ebner et al (70) have isolated nuclear mutants 
of S. cerevisiae in which the synthesis of just one of the three mitochondrial 
products of cytochrome oxidase is shut off. Similarly, other nuclear muta-
tions have been reported to specifically block the synthesis of cytochrome 
b or of the ATPase proteolipid without affecting the synthesis of the other 
mitochondrial products (71). 
Although there is abundant evidence that mitochondrial translation and/ 
or transcription are controlled by the nUcleocytoplasmic system of the cell 
(20, 72), the reverse does not appear to hold true. Most of the cytoplasmic 
products, including those that are destined to be integrated into enzymes 
containing mitochondrially derived subunits, are synthesized at near nor-
mal levels even when mitochondrial synthesis is inhibited. This is best seen 
in petite mutants of yeast that are totally unable to elaborate any mitochon-
drial products. Such mutants, nonetheless, have respiratory-deficient mito-
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chondrial organelles which, with the exception of the mitochondrial 
products, have a protein composition identical to those of wild-type yeast 
(73, 74). 
Properties of Mitochondrial Products 
Mitochondrial translation products represent some of the most hydro-
phobic proteins of the inner membrane. They are highly insoluble in water 
and tend to form large aggregates that can only be dispersed by means of 
powerful ionic detergents. These properties have been attributed to their 
high content of non polar amino acids (32,33,64, 75, 76). The mitochondri-
ally synthesized subunits of cytochrome oxidase, for example, average 10-
15% more nonpolar residues than do the other four subunits of the enzyme 
(32, 33, 75, 76). The ATPase proteolipid is an even more extreme case, 
having only 23% polar amino acids (64)-this is to be contrasted with 
values of 50-60% observed in most water soluble proteins (77). 
It has been speculated that the hydrophobic character of certain mito-
chondrial components necessitated an intraorganellar site of synthesis, 
thereby avoiding the logistic problem of transporting highly insoluble pro-
teins through the aqueous cytosolic phase. This interpretation, however, is 
not entirely satisfactory in view of the fact that many other hydrophobic 
proteins of mitochondria are known to be synthesized on cytoplasmic ribo-
somes and subsequently transported by still undefined mechanisms to the 
interior of the organelle. The ATPase proteolipid of N. crassa is a case in 
point. Even though the amino acid compositions and primary structures of 
the yeast and N. crassa proteolipids are very similar (78), they have been 
shown to have different synthetic origins (58). The yeast proteolipid is a well 
established mitochondrial product (64)-in N. crassa, the same protein has 
been shown to be synthesized in the cytoplasm (57,65). The hydrophobic 
properties of this component, therefore, did not interfere with the evolution-
ary process of transfer of a mitochondrial gene to the nucleus and concomi-
tantly of its transcription and translation in the cytoplasm. 
The notion that mitochondria are concerned with the synthesis of pro-
teins with structural functions has not been borne out by the existent 
evidence. Both cytochrome oxidase (33) and coenzyme QHrcytochrome 
c reductase (43, 44) contain at least one hemoprotein carrier synthesized 
in mitochondria. Our inability to assign functions to the other mitochon-
drial products arises from a general lack of knowledge about the functions 
of the different subunit polypeptides of the respiratory and ATPase com-
plexes. 
In Vitro Synthesis of Mitochondrial Products 
Initial attempts to identify the proteins synthesized by isolated mito-
chondria were hampered by poor incorporation of radioactive precursors 
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and technical difficulties in purifying the labeled products from small quan-
tities of mitochondria. These problems have been largely overcome and it 
is now generally recognized that mitochondria synthesize completed pro-
teins that are identical to the in vivo products. Poyton & Groot (79) have 
shown that isolated yeast mitochondria are capable of synthesizing the three 
large subunits of cytochrome oxidase. The in vitro products were integrated 
into a larger complex which could be precipitated with antisera to some of 
the smaller cytoplasmically made subunits. Presumably there is a sufficient 
endogenous pool of the cytoplasmic subunits to allow post-translational 
assembly of cytochrome oxidase. Although such experiments have not been 
extended to coenzyme QHrcytochrome c reductase and the ATPase com-
plex, there is substantial evidence from studies with yeast and mammalian 
cells (80, 81) that the relative proportions and electrophoretic mobilities of 
the major mitochondrial products formed in vitro and in vivo are very 
similar. 
Mitochondrial gene products have also been synthesized using poly(A)-
RNA purified from yeast mitochondria and translated in an E. coli or wheat 
germ ribosomal system. Padmanaban et al (82) found that total mitochon-
drial poly(A) containing messenger RNA gave a fourfold stimulation of 
PH] leucine incorporation in a cell-free ribosomal system. Some of the 
proteins made under these in vitro conditions cross-reacted with cyto-
chrome oxidase antibodies and comigrated with the authentic mitochondri-
ally synthesized subunits of the enzyme (82). 
A number of laboratories have tried to develop coupled transcription-
translation systems to study the gene products of mitochondrial DNA. 
While there have been some reports of the synthesis of immunochemically 
reactive cytochrome oxidase gene products when mitochondrial DNA was 
transcribed and translated in an E. coli system (83), in other studies the 
products formed were of low molecular weight and could not be related to 
any bona fide mitochondrial proteins (84). In view of recent advances in 
mitochondrial genetics and the tentative identification of many of the genes 
on mitochondrial DNA, the usefulness of cell free transcription-translation 
studies has been somewhat lessened. 
MITOCHONDRIAL GENES 
Mitochondria contain circular duplex DNA with a molecular weight rang-
ing from 1 X 107- 5 X 107, depending on the organism. The larger genome 
size is more prevalent among fungi, protists, and higher plants. Mammalian 
mitochondria tend to have smaller DNAs that are generally 1 X 107 daltons 
(9). 
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Mit and Syn Genes 
Most of our current knowledge of mitochondrial genes has come from 
studies of S. cerevisiae which has proven to be especially suitable for genetic 
analysis (85). The DNA of this yeast has a molecular weight of 5 X 107 
which is equivalent to about 75 kilobases (9). The first genes to be recog-
nized in the yeast genome coded for components of the mitochondrial 
protein synthetic machinery (9, 86). These have been designated as syn 
genes and they include the transfer and the ribosomal RNAs of mito-
chondria (9, 86, 87). At least 30 different mitochondrial tRNAs have been 
detected in S. cerevisiae (88). The major tRNA species of this yeast, repre-
senting the twenty common amino acids, all have been shown by hybridiza-
tion to be gene products of mitochondrial DNA (88-91). The total number 
of isoaccepting species is compatible with the Wobble hypothesis which 
suggests that in yeast there is no need for importation of cytoplasmic 
tRNAs into mitochondria. This is probably also true of N. crassa (92, 93) 
but not of animal mitochondria (94-95). For example, most of the tRNAs 
present in Tetrahymena mitochondria are transcribed from nuclear DNA; 
the mitochondrially encoded species are confined to the four amino acids, 
leucine, phenylalanine, tryptophan, and tyrosine (96). In at least some 
organisms, therefore, mitochondria make use of cytoplasmic tRNAs. 
In contrast to the RNA components, aminoacyl synthetases, protein 
synthesis initiation factors, and most of the ribosomal proteins have been 
shown to be nuclear gene products that are synthesized on cytoplasmic 
ribosomes (9). There is some evidence, however, that at least one ribosomal 
protein may be a mitochondrial product. The classical "poky" mutation in 
N. crassa has been correlated with the absence of a specific protein of the 
small ribosomal subunit (97). In S. cerevisiae, the mitochondrial gene prod-
uct, var 1, has also been found to be a component of the small ribosomal 
subunit (24). 
The second important class of mitochondrial genes are the mit genes 
which code for proteins that function in electron transport and oxidative 
phosphorylation. The existence of this class of genes has been suspected for 
a long time but was only recently established as the result of the isolation 
of new antibiotic-resistant mutants (98-100) and mit- mutants (101-104) of 
S. cerevisiae. The mit- mutants in particular have been instrumental in 
showing that many of the proteins synthesized by mitochondria are also 
gene products of mitochondrial DNA. To date, mit- mutations have been 
found to affect the three inner membrane complexes, cytochrome oxidase 
(101-104), coenzyme QHz-cytochrome c reductase (101-104), and the 
oligomycin-sensitive ATPase (105, 106). Based on genetic analyses of a 
large number of different mit- strains, six complementation groups have 
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been found (107) (Table 1). Three of the complementation groups (oxi 1, 
oxi 2, and ox; 3) code for products that have been tentatively identified to 
be the three mitochondrially synthesized subunits of cytochrome oxidases 
(108-109). Mutations that map in the cob complementation group are 
deficient in cytochrome b and have been convincingly shown to be in the 
structural gene of this respiratory carrier (46, 110). One group of ATPase-
deficient mutants (pho 2) is now known to have lesions in the proteolipid 
component of the ATPase (106, 111). This gene also contains the oil 1 and 
oil 3 resistance loci (111). The gene products of the other ATPase mutants 
(pho 1) has not yet been identified. Another mitochondrial translation 
product known to be encoded in mitochondrial DNA is the var I protein 
(23, 112). 
Although our information concerning mitochondrial genes is still frag-
mentary, it is nonetheless evident that of the nine proteins known to be 
synthesized in mitochondria, six have been documented to be specified by 
mitochondrial DNA. 
Map of Mitochondrial DNA 
All of the known mit- and antibiotic resistance markers of the mitochon-
drial genome of S. cerevisiae have now been localized on the circular map 
by a combination of genetic and physical mapping methods. Two ap-
proaches have been used in genetic mapping. 1. Co-retention and co-dele-
tion of the mutated alleles in the DNA of p- mutants (102, 113, 114). This 
type of analysis allows mutations to be positioned relative to each other on 
the wild-type genome and at the same time places limits on the retained 
segments of DNA in the p- mutants. 2. In some instance mutations have 
been mapped relative to each other and map distances obtained by recombi-
national analysis in two and three factorial crosses (46, 102). 
Various methods have been devised to locate mitochondrial genes on the 
physical map. Ribosomal and tRNA genes have been mapped by hybridiza-
Table 1 Complementation groups and gene products of the yeast genome 
Complementation 
Enzyme deficiency group Gene product 
Cytochrome oxidase oxi 1 sub unit 2 
Cytochrome oxidase oxi 2 subunit 3 
Cytochrome oxidase oxi 3 subunit 1 
Coenzyme QH2 -cytochrome 
c reductase cob cytochrome b 
ATPase pho 1 ? 
ATPase pho 2 subunit 9 
(proteolipid) 
MITOCHONDRIAL GENES AND TRANSLATION PRODUCTS 429 
tion to restriction fragments generated from wild-type (115, 116) or p-
DNAs (90). A number of mit- and antibiotic resistance markers have been 
localized by restriction analysis of genetically marked mit- and p- clones 
(117-119). In general, the results obtained by genetic and physical methods 
have been in good agreement and have provided a fairly unambiguous map 
of the mitochondrial genome of S. cerevisiae. The map presented in Figure 
1 shows the positions assigned to the known syn and mit genes as well as 
the antibiotic resistance markers, most of which have now been related to 
specific gene products. The map of the yeast genome reveals a considerable 
dispersity of genes that code for related functions. The three structural 
genes of cytochrome oxidase are separated by intervening regions contain-
ing syn and mit genes. The ribosomal RNA, tRNA, and ATPase genes are 
also scattered in different regions of the genome. This organizational feature 
argues against a coordinately controlled expression of genes by means of 
polycistronic messengers. By analogy with eucaryotic genes, those of the 
mitochondrion appear to be transcribed individually. 
Saturation of the Genome 
How inclusive is our present information on the genetic content of the S. 
cerevisiae mitochondrial genome? The evidence that most of the mit type 
of genes are now known is quite compelling. This is attested to by the fact 
that the more than a thousand mit- strains isolated and studied in differ-
ent laboratories all tend to fall into a limited number of genetic loci that 
compromise some six complementation groups. It must be kept in mind, 
however, that the mir class of mutants is selected on the basis of its 
inability to grow on nonfermentable substrates (101, 103, 104). Since this 
phenotype is most likely to result from mutations in gene products directly 
involved in respiratory functions (namely electron transport carriers), the 
selection procedure may exclude mutations that alter mitochondrial func-
tions in more subtle ways. Mutations in regulatory genes that might be 
expected to reduce or enhance the transcription of a structural gene without 
necessarily abolishing the capacity for respiration entirely, would not neces-
sarily be recognized by the selection procedures used. 
There are also gaps that need to be filled in regard to syn genes. While 
it is true that in S. cerevisiae the major tRNAs have been shown to be 
transcribed from mitochondrial DNA, there are many isoaccepting species 
present in mitochondria whose genetic origin and function have not been 
clarified. Nor is it known whether mitochondria code for protein factors 
that participate in or regulate mitochondrial protein synthesis. For exam-
ple, the paramomycin resistance marker, formerly thought to be in the 16S 
ribosomal RNA gene, has recently been shown to map in a restriction 
fragment that is adjacent to, but distinct from, the RNA gene (116). This 
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raises the possibility that paramomycin acts on some yet unknown compo-
nent of the translation machinery. These and related questions are most 
likely to be answered when alternative selection methods are devised for the 
isolation of new types of mitochondrial mutants. 
Constancy of the Mitochondrial Genome 
The map of the S. cerevisiae genome shown in Figure 1 is based on studies 
of different laboratory strains of this yeast. All the strains examined appear 
to have the same composition and relative position of genes. This is not to 
say, however, that intra-species differences do not exist. Both genetic and 
physical mapping data indicate considerable heterogeneity of the DNA 
among yeast strains. Detailed physical maps of mitochondrial DNA have 
now been obtained for at least four different strains. Based on the analysis 
of HpaII and HaeIII digests, Prunell & Bernardi (120) have concluded that 
there are frequent strain-specific insertions of deletions of DNA in different 
parts of the genome. Insertions of up to 3,000 base pairs have been noted 
in the segment of DNA included between the oli 1 and par 1 resistance loci 
(121). This region of the genome seems to be the most variable in the strains 
studied so far (121). 
Genetic data also point to considerable differences in gene spacer regions 
and even in the internal organization of genes. This is particularly evident 
in the cytochrome b (or cob region). In some strains mutations in cyto-
chrome b are genetically linked to the oli 1 resistance marker-in other 
Figure 1 Map of the mitochondrial genome of S. cerevisiae. The following designations are 
used for the antibiotic resistance loci: cap, chloramphenicol; ery, erythromycin; par, paromo-
mycin; ant, antimycin; oli, oligomycin. The mit complementation groups of Table I are 
indicated by the heavy lines. The 16S and 21S refer to the two ribosomal RNA genes and var 
1 to the 40,000-43,000 dalton mitochondrial products studied by Butow and co-workers (23, 
112). The approximate positions of the tRNA genes are indicated by dots. 
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strains they are completely unlinked, which suggests that the spacer be-
tween the ATPase proteolipid and cytochrome b genes varies in length 
depending on the strain (46). Even more intriguing discrepancies have been 
found in the properties of cytochrome b mutants of different strains. Thus, 
in some strains of S. cerevisiae, cytochrome b mutations fall into two 
genetically unlinked clusters or loci (cob 1 and cob 2) which behave as a 
single complementation group (46, 107). In other strains, the cytochrome 
b complementation group has been found to consist of six unlinked loci 
(box 1-6) (122)-many of the cob 1 and cob 2 mutations are nonetheless 
allelic to mutations in the various box loci (100). These observations are 
most simply explained by assuming the existence of insertions within the 
structural gene of cytochrome b. The genetic data indicate that the number 
and length of inserted sequences in the cytochrome b gene may be strain-
dependent. 
When mitochondrial DNA of S. cerevisiae is compared to other organ-
isms, the divergences are much more profound. Aside from differences in 
physical size, buoyant density, and restriction maps, there is also consider-
able variation in the genetic content of mitochondrial DNA. At present 
such information is limited almost entirely to the ribosomal and transfer 
RNA genes. In N. crassa the ribosomal RNAs are transcribed as a single 
328 precursor (123) and hybridization of the mature RNAs to restriction 
fragments indicates that they have a proximal location on the genome (93). 
This also appears to be true of most animal mitochondrial genomes (124, 
125). There are equally significant differences in the number oftRNA genes. 
In S. cerevisiae and N. crassa, tRNA species corresponding to the twenty 
amino acids have been shown to be transcribed from mitochondrial DNA 
(88-91,93). Animal mitochondria, however, have fewer tRNA genes (86, 
87, 95). It was already pointed out that in Tetrahymena isoacceptors for 
only four amino acids are capable of hybridizing to mitochondrial DNA 
(96). In mammalian mitochondria, the number of hybridizable species is 
larger but again some of the organellar tRNAs appear to be imported from 
the cytoplasm. Attardi and co-workers have reported that in HeLa cells the 
tRNAs for twelve amino acids hybridize to the heavy strand of mitochon-
drial DNA, five other amino acids hybridize to the light strand, and four 
fail to hybridize altogether. Both strands of this genome are therefore 
transcribed (126). It is not known ifthis is also true for mitochondrial DNA 
of S. cerevisiae. 
ATPase PROTEOLIPID 
The proteolipid of the yeast ATPase is presently the best understood mito-
chondrial gene and translation product. This protein is particularly interest-
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ing since there is now very good evidence that in N. crassa it is coded by 
a nuclear gene (127) and is translated on cytoplasmic ribosomes (58). The 
transfer of a gene from the mitochondrion to the nucleus (or vice versa) 
represents an important change in the cell which might be experimentally 
exploited to test some of the current theories of mitochondrial evolution 
(128, 129). 
DCCD-Binding Properties 
Dicyclohexylcarbodiimide (DCCD) is a potent inhibitor of oxidative phos-
phorylation and of the mitochondrial ATPase (130). Cattell et al (131) 
showed that DCCD reacts covalently with a low molecular weight proteo-
lipid of beef heart mitochondria which could be extracted with chloroform: 
methanol and purified on silicic acid. The proteolipid was named the 
DCeD-binding protein and was later shown to be a component of the 
oligomycin-sensitive ATPase (58, 132). The DCCD-binding protein has 
also been found to be present in the yeast ATPase (65). The yeast protein 
is one of the mitochondrially synthesized subunits (subunit 9) of the 
ATPase (63,64). It is interesting that there are approximately six molecules 
of the protein per enzyme and these form a hexameric complex that resists 
depolymerization by SDS and other detergents (58, 63). The hexamer, 
however, is dissociated by organic solvents and by strong alkali or base (64). 
Although the DCCD-binding protein has also been demonstrated to be a 
component of the N. crassa ATPase, it is synthesized in this organism on 
cytoplasmic rather than mitochondrial ribosomes. Jackl & Sebald (57) have 
shown that the N. crassa proteolipid becomes labeled with a radioactive 
amino acid in the presence of chloramphenicol but not cycloheximide. 
Similar to the yeast enzyme, the N. crassa ATPase appears to have six 
proteolipid subunits but a stable hexameric complex has not been detected 
(57, 58). 
Function 
In addition to binding DCCD, the proteolipid probably also contains the 
oligomycin binding site of the ATPase. Criddle et al (133) have postulated 
that one of the keto groups of oligomycin may form a Schiff base with an 
amino group on the protein. When the yeast ATPase was reacted with 
oligomycin and reductively alkylated with PH] sodium borohydride, the 
radioactive label was associated exclusively with a protein that was soluble 
in chloroform: methanol and whose electrophoretic migration on SDS 
polyacrylamide gels was identical to the proteolipid. Since ATPase prepara-
tions obtained from oligomycin-resistant mutants failed to incorporate the 
radioactive label into the proteolipid, these authors concluded that the 
oligomycin-binding site of the ATPase resides in the proteolipid (133). 
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Although it is reasonable to conclude that the binding sites for DeeD, 
oligomycin, and perhaps other inhibitors of the ATPase are present in the 
proteolipid, the precise function of this protein is still obscure. There is some 
recent evidence, however, suggesting that the proteolipid may act as a 
protonophore. It has been reported that the yeast proteolipid increases the 
permeability of artificial lipid membranes to protons (134). These experi- . 
ments were especially interesting in view of the fact that proton transport 
in this model system was inhibited by oligomycin when the source of 
proteolipid was a wild-type oligomycin-sensitive strain of yeast. When the 
protein was obtained from an oligomycin-resistant mutant, the sensitivity 
to the inhibitor was decreased. Whether the proteolipid acts as a proton 
carrier or channel needs to be studied further but the above results are 
consistent with the earlier suggestion that oligomycin inhibits oxidative 
phosphorylation by blocking the discharge of protons generated during 
electron transport across the inner membrane (135). 
Amino Acid Sequence 
It is possible to obtain high yields of pure ATPase proteolipid directly from 
mitochondria by a relatively simple procedure involving extraction with 
chloroform: methanol and thin layer chromatography. This fact, combined 
with its small size, have made it possible to sequence the ATPase proteolip-
ids of yeast and other types of mitochondria (111, 136). The primary 
structure of the various proteolipids was established by solid phase sequenc-
ing of the total polypeptide and of cyanogen bromide fragments. 
The primary structures of the proteolipids from S. cerevisiae and N. 
crassa are shown in Figure 2. Both proteins are extremely hydrophobic as 
was already evident from their amino acid compositions. Even though the 
yeast and N. crassa proteins are synthesized in two different compartments 
of the cell, they show a great deal of sequence homology-this is especially 
evident in the amino acid sequences spanning residues 17-41 and 51-68. It 
is also significant that DeeD has been found to bind covalently to the 
glutamic acid residues that occur at positions 59 and 64 in the yeast and 
N. crassa proteolipids, respectively. The sequence homologies and identity 
of the DeeD-binding residues argue strongly in favor of a common genetic 
derivation of the two proteins. It is also interesting to note that the N. crassa 
proteolipid contains five extra amino acids at the amino terminus and has 
a tyrosine instead of a formyl methionine as the amino terminal residue. The 
biosynthetic evidence on the sites of translation of the two proteins is thus 
nicely complemented by the sequence data. Since mitochondria utilize for-
myl methione as the initiator (22), the occurrence of this amino acid in the 
yeast but not the N. crassa protein is consistent with their proposed syn-
thetic origins (58). 
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Figure 2 Primary structures of the ATPase proteolipids (DCCD-binding protein) of S. 
cerevisiae and N. crassa_ The yeast protein (upper sequence) starts with an fMet at the amino 
terminus and the Neurospora protein (lower sequence) with a tyrosine. 
Genetic Specification of the Proteolipid 
There was some earlier evidence that the oli 1 resistance locus is in the 
structural gene of the proteolipid (137, 138). Mutations in oli 1 were found 
to modify certain properties of the yeast proteolipid (137). The localization 
of alleles conferring the resistance phenotype in the structural gene of the 
proteolipid has been fully confirmed by protein sequence data (111). At 
present two different amino acid substitutions are known to occur in oli 1 
resistant mutants. In one group of mutants a serine replaces cysteine at 
position 65 (111); in another, a phenylalanine replaces leucine at position 
53 (78, 111). Oli 3 (oli 3 and oli 1 resistant mutants are distinguished by 
the cross-resistance of the former but not the latter to venturicidin) and pho 
2 mutants also have amino acid substitutions in the proteolipid (111). These 
data established conclusively that in yeast, the ATPase proteolipid is a 
product of a mitochondrial gene. 
Sebald et al (127) have isolated oligomycin-resistant mutants of N. crassa. 
The growth of these strains is inhibited by oligomycin and as in yeast this 
property results from a decreased sensitivity of the mitochondrial ATPase 
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to the antibiotic. In contrast to yeast, however, all the oligomycin-resistant 
strains of N. crassa were determined to have nuclear mutations that were 
linked to markers on chromosome VII (127). The amino acid sequence of 
the proteolipid from one such strain indicated a substitution of a serine for 
a phenylalanine at residue 61 (127). These results indicate that the struc-
tural gene of the proteolipid of N. crassa is in nuclear DNA and explains 
the extramitochondrial site of translation of the protein in this organism 
(47). 
The biosynthesis and genetics of the proteolipid of animal cells have not 
been studied. There is some evidence that in X. laevis the proteolipid is 
synthesized in the cytoplasm and is probably a nuclear gene product (39). 
If this can be confirmed it would suggest that there may have been an early 
evolutionary transfer of this mitochondrial gene to the nucleus and that in 
more highly evolved eucaryotic cells it is a nuclear gene product whose 
messenger is translated in the cytoplasm. 
Sequence of the Proteolipid Gene of Saccharomyces cerevisiae 
Mitochondrial DNA is an especially attractive material for sequencing 
since it is present only in eucaryotic organisms, but in view of its postulated 
procaryotic origin, it may preserve some features of both types of genomes. 
In addition, it is of sufficiently small size that one may hope to obtain its 
complete nucleotide sequence. This information would be useful in under-
standing how mitochondrial genes are organized and perhaps how their 
expression may be regulated. Since DNA sequence data can be most mean-
ingfully interpreted if the primary structure of the gene products is known, 
the ATPase proteolipid gene has been an obvious choice for sequencing. 
As a result of recent studies, the complete nucleotide sequence of the 
yeast proteolipid gene has been obtained (Figure 3). These data were ob-
tained from the analysis of mitochondrial DNA of a p- mutant that con-
tained the genetic markers oli 1 and pho 2 but had lost all the other 
currently known markers of the yeast genome (140). The retained segment 
of mitochondrial DNA in the p- mutant was ascertained to be 1.8 kilobases 
long or approximately 2.5% of the original genome. Since oli 1 and pho 2 
were known to be within the structural gene of the proteolipid, the 1.8-
kilobase piece of DNA could safely be assumed to have the structural gene 
sequence. 
The DNA sequence shows that there is an almost complete agreement 
between the primary structure of the proteolipid and the nucleotide se-
quence of its gene. The one exception is the amino acid residue at position 
46 which, from the DNA data, should be a leucine rather than a threonine. 
The DNA sequence also confirms the utilization of the codons of the 
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Figure 3 Nucleotide sequence of the ATPase proteolipid gene of S. cerevisiae. The DNA used 
for sequencing was obtained from a strain that was resistant to oligomycin (oli 1 locus) and 
was shown to have a substitution of a phenylalanine for a leucine at residue 53 of the 
proteolipid (142). 
universal code by mitochondria and of one of the standard termination 
codons (ochre). Despite the fact that the universal codons are used, there 
appears to be little degeneracy in the code. This is seen in the preferential 
utilization of the UUA codon for leucine and UUC for phenylalanine. 
Whether this is true for other mitochondrial genes will have to await further 
sequence data. Another feature of the DNA that is not shown in Figure 3, 
is a long sequence rich in A+T that follows the gene. Some 1,000 nucleo-
tides following the structural gene have been sequenced and, with the 
exception of two short regions that are rich in G+C, the DNA consists 
almost exclusively of A+T. The function of the A+T- and G+C- rich 
sequences which occur throughout the entire genome (141) is not yet known 
but may be important in the regulation of gene expression. 
FUTURE PROBLEMS 
Much of the recent work in mitochondrial biogenesis has revolved around 
the following three questions. What are the mechanisms of assembly of 
inner membrane complexes that contain both cytoplasmically and mito-
chondrially made subunits? What are the constituent genes of mitochon-
drial DNA? How are mitochondrial genes organized and what regulates 
their expression? 
The progress made on all three fronts has been impressive and, as a 
consequence, many young investigators have been attracted to an already 
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fast growing field. There are still outstanding problems that need to be 
resolved and it is possible to make some predictions as to what approaches 
will be taken during the next few years. 
The assembly of multisubunit enzymes such as cytochrome oxidase and 
the ATPase is still a poorly understood process. There are several related 
questions that can best be studied with mutants that have lesions in either 
structural or regulatory genes that control the biosynthesis of these en-
zymes. Fortunately there are now a large number of mitochondrial as well 
as nuclear mutants of S. cerevisiae that can be put to use in exploring the 
sequence in which the different subunits are integrated during the course 
of enzyme assembly. Many steps in bacteriophage genesis have been de-
duced from the intermediates found in assembly-deficient mutants and this 
basic approach may be equally successful in probing the assembly of mito-
chondrial enzymes. In addition, mutants can be used to study possible 
regulatory proteins that modulate the expression of mitochondrial struc-
tural genes. It was pointed out that in S. cerevisiae, there are nuclear 
mutations that selectively shut off the synthesis of single mitochondrial 
translation products. Such strains are likely to have mutations in regulatory 
proteins that may repress or activate the transcription or translation of 
specific mitochondrial genes. This interesting class of mutants has received 
little attention up to now and may provide clues as to how cytoplasmic 
factors regulate mitochondrial gene expression. 
Even though most of the structural genes of mitochondrial DNA are now 
known, it is not excluded that other genes may be present that have not yet 
been identified. It is also still questionable whether the minor isoaccepting 
species of tRNAs present in mitochondria are separate gene products of 
mitochondrial DNA or post-transcriptional modification products. The 
complete saturation of the mitochondrial genome requires more extensive 
searches for mutants employing new selection procedures. It is difficult to 
understand, for example, why only a few tRNA and ribosomal RNA mu-
tants have been found up to now. Equally strange is that no single mutant 
in the var 1 protein has been isolated despite the fact that it is the largest 
gene product of mitochondrial DNA. These observations tend to indicate 
that mutations in certain mitochondrial genes may not be clearly expressed 
and may not necessarily lead to total absence of growth on nonfermentable 
substrates, the standard test currently used to obtain mitochondrial mu-
tants. 
The third and probably most promising line of research is the sequence 
analysis of mitochondrial DNA. The first efforts in this direction have 
yielded promising results in the sense that most of the techniques that have 
been developed in recent years for the sequencing of procaryotic and eu-
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caryotic DNAs can be applied without major complications to mitochon-
drial DNA (139). Since the mitochondrial genome is many orders ofmagni-
tude smaller than the smallest nuclear DNA, it is safe to assume that this 
will be the first eucaryotic DNA to be completely sequenced. Knowledge 
of the DNA sequence should answer the already mentioned question of 
whether the organization of mitochondrial genes follows the general out-
lines of eucaryotic or procaryotic genomes. Furthermore, it will tell us 
something about the regulation of the genome. Finally, the DNA sequence 
may turn out to be the least cumbersone way of obtaining the primary 
structure of mitochondrial translation products that have proven to be 
difficult to seque:J.ce by conventional methods. 
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